Drug Addiction Treatment Market Report 2026

The drug addiction treatment market size has grown strongly in recent years. It will grow from $22.9 billion in 2025 to $25.17 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of substance abuse disorders, expansion of rehabilitation infrastructure, increased availability of detoxification services, growing public health awareness initiatives, wider acceptance of structured addiction treatment programs.

The drug addiction treatment market size is expected to see strong growth in the next few years. It will grow to $36.32 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for personalized addiction treatment plans, rising integration of digital health platforms, expansion of community-based rehabilitation services, growing focus on mental health parity, increased government funding for addiction recovery programs. Major trends in the forecast period include increasing adoption of medication-assisted treatment programs, rising integration of behavioral and psychological therapies, growing expansion of outpatient and community-based care models, enhanced focus on long-term aftercare and relapse prevention, increasing use of digital monitoring and support tools.

The rising prevalence of substance use disorders is expected to drive the growth of the drug addiction treatment market in the coming years. Substance use disorders are chronic conditions characterized by compulsive use of drugs or alcohol despite harmful consequences, significantly impacting mental, physical, and social well-being. This increase is linked to rising stress and mental health challenges, as well as modern lifestyles marked by social pressures, economic instability, and easy access to addictive substances. Drug addiction treatment addresses substance use disorders by providing medical and psychological support to reduce dependency, enhance overall well-being, and facilitate long-term recovery through structured rehabilitation programs. For example, in December 2023, the UK-based public health agency, Office for Health Improvement & Disparities (OHID), reported that between April 2022 and March 2023, 290,635 adults engaged with drug and alcohol services, a slight increase from 289,215 the previous year. Thus, the growing prevalence of substance use disorders is expected to propel the drug addiction treatment market.

Key players in the drug addiction treatment market are focusing on technological innovations, such as telehealth appointments, to improve accessibility, patient engagement, and convenience for individuals with substance use disorders. Telehealth appointments involve medical consultations and healthcare services delivered remotely through digital communication technologies. For instance, in February 2023, Jovive Health, a US-based multispecialty healthcare provider, launched Medication-Assisted Treatment (MAT) services for patients with Opioid Use Disorder (OUD) across its clinics in California, Nevada, and Illinois. The program uses FDA-approved medications, including buprenorphine, to reduce withdrawal symptoms and cravings, supporting patients in safely discontinuing opioid use. Jovive’s services include multi-appointment individualized treatment plans, convenient online booking, walk-in consultations, extended clinic hours, and telehealth appointments, making OUD treatment more accessible and patient-centric.

In March 2023, Indivior PLC, a US-based pharmaceutical company, acquired Opiant Pharmaceuticals, Inc. for an undisclosed amount. Through this acquisition, Indivior expanded its addiction treatment portfolio by incorporating Opiant’s late-stage assets, including OPNT003, a novel investigational opioid overdose therapy, and gained a skilled team to advance its mission of providing life-transforming treatments for substance use disorders. The acquisition also positions Indivior for potential revenue growth from OPNT003 and broadens its pipeline with additional investigational therapies for alcohol and cannabinoid use disorders. Opiant Pharmaceuticals, Inc. is a US-based specialty pharmaceutical company focused on developing pharmacological treatments for substance use, addictive, and eating disorders.

Major companies operating in the drug addiction treatment market are Novartis AG, Dr. Reddy’s Laboratories Ltd., Acadia Healthcare, Hikma Pharmaceuticals plc, Alkermes plc, Indivior PLC, Emergent BioSolutions Inc., Workit Health, Rusan Pharma Pvt. Ltd., Boulder Care, Bicycle Health, Eleanor Health, Affect Therapeutics, Forge Health, Orexo AB, BioCorRx Inc., Kinoxis Therapeutics Pty. Ltd., Addinex Technologies Inc., PursueCare, Aliya Health Group.

North America was the largest region in the drug addiction treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug addiction treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the drug addiction treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the drug addiction treatment market by increasing costs associated with imported pharmaceutical ingredients, medical devices, diagnostic tools, and digital health infrastructure used in treatment and monitoring programs. Hospital pharmacies, rehabilitation centers, and outpatient clinics in North America and Europe are most affected due to reliance on imported medications and equipment, while Asia-Pacific faces pricing pressures on pharmaceutical supply chains. These tariffs are contributing to higher treatment costs and budget constraints for care providers. However, they are also encouraging domestic pharmaceutical manufacturing, local sourcing of treatment supplies, and investment in regionally developed digital therapeutic solutions.

The drug addiction treatment market research report is one of a series of new reports that provides drug addiction treatment market statistics, including drug addiction treatment industry global market size, regional shares, competitors with a drug addiction treatment market share, detailed drug addiction treatment market segments, market trends and opportunities, and any further data you may need to thrive in the drug addiction treatment industry. This drug addiction treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Drug addiction treatment involves professional medical and therapeutic interventions aimed at helping individuals stop or reduce substance use, manage withdrawal symptoms, and achieve long-term recovery and rehabilitation. These treatments assist individuals in overcoming substance dependence, restoring physical and mental health, and reintegrating into society through structured medical and therapeutic programs.

The main types of drug addiction treatment include opioid addiction, benzodiazepine addiction, barbiturate addiction, and others. Opioid addiction is a chronic disorder marked by compulsive opioid use despite harmful consequences, resulting in physical dependence and psychological cravings. Treatment options include inpatient rehabilitation, outpatient rehabilitation, detoxification services, aftercare and continuity programs, and medication-assisted treatment (MAT), with administration routes such as oral, parenteral, and others. Drug addiction treatments are provided through hospital pharmacies, retail pharmacies, online pharmacies, and other channels, with key end-users including rehabilitation centers, hospitals, clinics, and others.

The drug addiction treatment market includes revenues earned by entities by providing services such as counseling and psychotherapy services, behavioral therapy programs, family support and intervention services, telehealth and virtual recovery services, and relapse prevention and monitoring programs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.